Prognostic Significance of VEGF Expression Evaluated by Quantitative Immunohistochemical Analysis in Colorectal Cancer

Journal of Surgical Research

Volumn 147, Issue 1, 2008, Pages 99-107

  Zafirellis, Kyriakos ^a   Agrogiannis, George ^b   Zachaki, Aglaia ^a   Gravani, Katerina ^a   Karameris, Andreas ^c   Kombouras, Christos ^a  

^a General Hospital of Karditsa   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Veterans Administration Hospital NIMTS   (Greece)

Author keywords

colorectal cancer; image analysis; immunohistochemistry; prognosis; tissue microarrays; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43049147668     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.05.041     Document Type: Article

References (45)

1. Boyle P., and Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 16 (2005) 481
2. Obrand D.I., and Gordon P.H. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 40 (1997) 15
3. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4
4. Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1991) 11947
5. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844
6. Camp R.L., Dolled-Filhart M., and Rimm D.L. X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10 (2004) 7252
7. Altman D.G., Lausen B., Sauerbrei W., et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86 (1994) 829
8. Weitz J., Koch M., Debus J., et al. Colorectal cancer. Lancet 365 (2005) 153
9. Folkman J. What is the evidence that tumors are angiogenesis-dependent?. J Natl Cancer Inst 82 (1990) 4
10. Martiny-Baron G., and Marme D. VEGF-mediated tumor angiogenesis: A new target for cancer therapy. Curr Opin Biotechnol 6 (1995) 675
11. Ishigami S.I., Arii S., Furutani M., et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78 (1998) 1379
12. Takahashi Y., Kitadai Y., Bucana C.D., et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 (1995) 3964
13. Tokunaga T., Oshika Y., Abe Y., et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77 (1998) 998
14. Kang S.M., Maeda K., Onoda N., et al. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 74 (1997) 502
15. Lee J.C., Chow N.H., Wang S.T., et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36 (2000) 748
16. Wong J.H., Steinemann S., Tom P., et al. Volume of lymphatic metastases does not independently influence prognosis in colorectal cancer. J Clin Oncol 20 (2002) 1506
17. Sobin L.H., and Wittekind C. UICC: TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, Inc., New York 74
18. Ferrara N., and Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161 (1989) 851
19. Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983
20. Gross J.L., Moscatelli D., Jaffe E.A., et al. Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol 95 (1982) 974
21. Nagy J.A., Brown L.F., Senger D.R., et al. Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948 (1989) 305
22. Blood C.H., and Zetter B.R. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1032 (1990) 89
23. Cascinu S., Graziano F., Catalano V., et al. An analysis of p53. BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumor recurrence and event-free survival of patients treated with adjuvant chemoradiation. Br J Cancer 86 (2002) 744
24. Galizia G., Lieto E., Ferraraccio F., et al. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10 (2004) 3490
25. Zheng S., Han M.Y., Xiao Z.X., et al. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 9 (2003) 1227
26. Ferroni P., Spila A., Martini F., et al. Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer. Oncology 69 (2005) 145
27. Kondo Y., Arii S., Furutani M., et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer 88 (2000) 1820
28. Des Guetz G., Uzzan B., Nicolas P., et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94 (2006) 1823
29. Cascinu S., Staccioli M.P., Gasparini G., et al. Expression of vascular endothelial growth factor can predict event-free survival in Stage II colon cancer. Clin Cancer Res 6 (2000) 2803
30. Takahashi Y., Tucker S.L., Kitadai Y., et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132 (1997) 541
31. Kaio E., Tanaka S., Kitadai Y., et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 64 (2003) 61
32. Nanni O., Volpi A., Frassineti G.L., et al. Role of biological markers in the clinical outcome of colon cancer. Br J Cancer 87 (2002) 868
33. Hall T.L., and Fu Y.S. Applications of quantitative microscopy in tumor pathology. Lab Invest 53 (1985) 5
34. Altman D.G. Categorizing continuous variables. Br J Cancer 64 (1991) 975
35. Chung G.G., Provost E., Kielhorn E.P., et al. Tissue microarray analysis of β-catenin in colorectal cancer shows nuclear phospho-β-catenin is associated with a better prognosis. Clin Cancer Res 7 (2001) 4013
36. Wu A.W., Gu J., Li Z.F., et al. COX-2 expression and tumor angiogenesis in colorectal cancer. World J Gastroenterol 10 (2004) 2323
37. Moertel C.G., Fleming T.R., Macdonald J.S., et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of Stage III colon carcinoma: A final report. Ann Intern Med 122 (1995) 321
38. Mamounas E., Wieand S., Wolmark N., et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17 (1999) 1349
39. Galandiuk S., Wieand H.S., Moertel C.G., et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174 (1992) 27
40. Esteban J.M., Ahn C., Mehta P., et al. Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer. Am J Clin Pathol 102 (1994) 158
41. Camp R.L., Chung G.G., and Rimm D.L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8 (2002) 1323
42. Fernebro E., Bendahl P.O., Dictor M., et al. Immunohistochemical patterns in rectal cancer: Application of tissue microarray with prognostic correlations. Int J Cancer 111 (2004) 921
43. Resnick M.B., Routhier J., Konkin T., et al. Epidermal growth factor receptor, c-MET, β-catenin, and p53 expression as prognostic indicators in Stage II colon cancer: A tissue microarray study. Clin Cancer Res 10 (2004) 3069
44. Fernebro E., Dictor M., Bendahl P.O., et al. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med 126 (2002) 702
45. Jourdan F., Sebbagh N., Comperat E., et al. Tissue microarray technology: Validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443 (2003) 115